Impact of the Additive Effect of Angiotensin-Converting Enzyme Inhibitors and/or Statins with Antiplatelet Medication on Mortality After Acute Ischaemic Stroke

Impact of the Additive Effect of Angiotensin-Converting Enzyme Inhibitors and/or Statins with Antiplatelet Medication on Mortality After Acute Ischaemic Stroke

There has been recent interest in combining antiplatelets, angiotensin-converting enzyme inhibitors (ACEIs) and statins in primary and secondary ischaemic stroke prevention. This observational study was performed to evaluate the impact of adding ACEIs and/or statins to antiplatelets on post-stroke i...

Full description

Bibliographic Details
Main Authors: Al-Jabi, S.W (Author), Aziz, N.A (Author), Hassan, Y. (Author), Looi, I. (Author), Zyoud, S.H (Author)
Format: Article
Language:English
Subjects:
adult
aged
Aged
Aged, 80 and over
Angiotensin-Converting Enzyme Inhibitors
antithrombocytic agent
article
brain ischemia
Brain Ischemia
cardiovascular risk
controlled study
death
demography
dipeptidyl carboxypeptidase inhibitor
drug effect
Drug Therapy, Combination
female
Female
Hospital Mortality
human
Humans
hydroxymethylglutaryl coenzyme A reductase inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors
major clinical study
Malaysia
male
Male
medical record review
Middle Aged
mortality
observational study
Platelet Aggregation Inhibitors
Primary Prevention
priority journal
Retrospective Studies
Risk Factors
Secondary Prevention
Stroke
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items